24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Omnix Medical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:14
“The revolutionary AI social network is largely humans operating fleets of bots”
10:27
“Israeli tech post-October 7th could not be in a better position”
10:26
“It may feel uneasy, but letting software act independently isn’t optional, it’s necessary for survival today”
10:24
“One of the most undervalued opportunities is next-gen HR and talent intelligence”
More stories
Buzz
Most popular
Daily
Weekly
1
Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”
2
Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race
3
Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion
4
After $400M cyber exit, ex-IntSights CEO raises $11M to build AI app for personalized sports highlights
5
“SaaS is dying as a business category”
More news
Omnix Medical
3 stories about Omnix Medical
Omnix Medical raises $25 million Series C to tackle drug-resistant infections
15.10.25
|
CTech
Israeli biotech secures funding to complete Phase II trials for its novel antimicrobial peptide therapy.
Israeli biopharma startup Omnix Medical awarded €10.8 million from EU to fight drug-resistant bacteria
26.01.21
|
Meir Orbach
The novel agents developed by Omnix are designed as an alternative to classical antibiotics
Omnix Medical completes $8.5 million round to develop next-generation antibiotics for treatment of life-threatening infections
03.11.20
|
Meir Orbach
The Israeli startup has successfully completed testing in animals and the new funding will allow it to begin clinical trials with humans